Harbour Investment Management LLC Novo Nordisk A S Transaction History

Harbour Investment Management LLC

  • $214 Million
  • Q1 2025

A detailed history of Harbour Investment Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Harbour Investment Management LLC holds 83,461 shares of NVO stock, worth $5.77 Million. This represents 2.71% of its overall portfolio holdings.

Number of Shares
83,461
Previous 83,911 0.54%
Holding current value
$5.77 Million
Previous $7.22 Million 19.71%
% of portfolio
2.71%
Previous 3.24%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 29, 2025
SELL
$69.3 - $90.95 $31,185 - $40,927
-450 Reduced 0.54%
83,461 $5.8 Million
Q4 2024

Feb 10, 2025
SELL
$85.0 - $120.04 $54,400 - $76,825
-640 Reduced 0.76%
83,911 $7.22 Million
Q3 2024

Oct 29, 2024
SELL
$119.07 - $145.42 $501,880 - $612,945
-4,215 Reduced 4.75%
84,551 $10.1 Million
Q2 2024

Jul 22, 2024
SELL
$122.71 - $146.91 $469,243 - $561,783
-3,824 Reduced 4.13%
88,766 $12.7 Million
Q1 2024

May 08, 2024
SELL
$102.11 - $135.92 $122,532 - $163,103
-1,200 Reduced 1.28%
92,590 $11.9 Million
Q4 2023

Feb 09, 2024
SELL
$87.78 - $105.45 $212,427 - $255,189
-2,420 Reduced 2.52%
93,790 $9.7 Million
Q3 2023

Nov 14, 2023
BUY
$90.94 - $199.54 $4.25 Million - $9.33 Million
46,760 Added 94.56%
96,210 $8.75 Million
Q2 2023

Aug 11, 2023
SELL
$155.98 - $172.65 $155,356 - $171,959
-996 Reduced 1.97%
49,450 $8 Million
Q1 2023

May 12, 2023
SELL
$132.34 - $159.14 $14,557 - $17,505
-110 Reduced 0.22%
50,446 $8.03 Million
Q4 2022

Feb 10, 2023
SELL
$102.55 - $135.33 $87,167 - $115,030
-850 Reduced 1.65%
50,556 $6.84 Million
Q3 2022

Nov 15, 2022
SELL
$95.28 - $116.93 $21,914 - $26,893
-230 Reduced 0.45%
51,406 $5.12 Million
Q2 2022

Aug 15, 2022
SELL
$103.24 - $121.81 $126,985 - $149,826
-1,230 Reduced 2.33%
51,636 $5.75 Million
Q1 2022

May 16, 2022
SELL
$93.1 - $112.54 $93,658 - $113,215
-1,006 Reduced 1.87%
52,866 $5.87 Million
Q4 2021

Feb 14, 2022
SELL
$95.88 - $117.08 $9,588 - $11,708
-100 Reduced 0.19%
53,872 $6.03 Million
Q3 2021

Nov 15, 2021
SELL
$84.42 - $106.62 $35,456 - $44,780
-420 Reduced 0.77%
53,972 $5.18 Million
Q2 2021

Aug 16, 2021
BUY
$67.66 - $84.76 $60,758 - $76,114
898 Added 1.68%
54,392 $4.56 Million
Q1 2021

May 17, 2021
SELL
$67.06 - $75.82 $44,930 - $50,799
-670 Reduced 1.24%
53,494 $3.61 Million
Q3 2020

Oct 22, 2020
BUY
$63.69 - $70.22 $100,439 - $110,736
1,577 Added 3.0%
54,164 $3.76 Million
Q2 2020

Jul 31, 2020
SELL
$58.54 - $67.94 $87,810 - $101,910
-1,500 Reduced 2.77%
52,587 $3.44 Million
Q1 2020

Apr 17, 2020
SELL
$49.46 - $64.78 $8,408 - $11,012
-170 Reduced 0.31%
54,087 $3.26 Million
Q4 2019

Feb 04, 2020
SELL
$49.86 - $58.26 $4,138 - $4,835
-83 Reduced 0.15%
54,257 $3.14 Million
Q3 2019

Nov 08, 2019
SELL
$47.54 - $53.43 $26,147 - $29,386
-550 Reduced 1.0%
54,340 $2.81 Million
Q2 2019

Jul 26, 2019
SELL
$46.79 - $52.47 $14,972 - $16,790
-320 Reduced 0.58%
54,890 $2.8 Million
Q1 2019

May 03, 2019
SELL
$46.36 - $52.63 $56,791 - $64,471
-1,225 Reduced 2.17%
55,210 $2.89 Million
Q4 2018

Feb 08, 2019
SELL
$41.54 - $47.25 $34,270 - $38,981
-825 Reduced 1.44%
56,435 $2.6 Million
Q3 2018

Nov 05, 2018
SELL
$46.76 - $51.24 $14,028 - $15,372
-300 Reduced 0.52%
57,260 $2.7 Million
Q2 2018

Jul 31, 2018
SELL
$44.29 - $50.42 $54,698 - $62,268
-1,235 Reduced 2.1%
57,560 $2.66 Million
Q1 2018

Apr 30, 2018
SELL
$48.49 - $58.14 $61,339 - $73,547
-1,265 Reduced 2.11%
58,795 $2.9 Million
Q4 2017

Feb 02, 2018
SELL
$47.53 - $53.73 $390,696 - $441,660
-8,220 Reduced 12.04%
60,060 $3.22 Million
Q3 2017

Nov 07, 2017
BUY
$41.15 - $49.22 $2.81 Million - $3.36 Million
68,280
68,280 $3.29 Million

Others Institutions Holding NVO

# of Institutions
1,817
Shares Held
339M
Call Options Held
11.9M
Put Options Held
10.6M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $156B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Harbour Investment Management LLC Portfolio

Follow Harbour Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email